Ceribell (CBLL) Gains from Sales and Divestitures (2024 - 2026)
Ceribell (CBLL) reported Gains from Sales and Divestitures of $96073.0 for Q1 2026, up 670.56% on a YoY basis from $12468.0 in Q1 2025, and down 51.96% quarter-over-quarter from $199975.0 in Q4 2025.
Ceribell (CBLL) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Ceribell has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $96073.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 670.56% year-over-year to $96073.0; the trailing twelve-month figure through Mar 2026 stood at $96073.0 (up 670.56% YoY), and the FY2025 full-year result was $199975.0, up 16040.03% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $96073.0, down from $199975.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $199975.0 in Q4 2025, with the low at $1239.0 in Q4 2024.
- Historically, Gains from Sales and Divestitures has averaged $82008.0 across 3 years, with a median of $78378.0 in 2025.
- Annual changes were most pronounced in 2025 — Gains from Sales and Divestitures soared 16040.03% — and 2026, when it jumped 670.56%.
- Ceribell's Gains from Sales and Divestitures stood at $1239.0 in 2024, then soared by 16040.03% to $199975.0 in 2025, then tumbled by 51.96% to $96073.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $96073.0 (Q1 2026), $199975.0 (Q4 2025), and $121610.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Ceribell | 679.82 Mn | 538.64 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96,073.00 |
| Mar 31, 2026 | 96,073.00 |
| Dec 31, 2025 | 199,975.00 |
| Dec 31, 2025 | 199,975.00 |
| Sep 30, 2025 | 121,610.00 |
| Sep 30, 2025 | 121,610.00 |
| Jun 30, 2025 | 60,683.00 |
| Jun 30, 2025 | 60,683.00 |
| Mar 31, 2025 | 12,468.00 |
| Mar 31, 2025 | 12,468.00 |
| Dec 31, 2024 | 1,239.00 |
| Dec 31, 2024 | 1,239.00 |